These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Comparison of ultrasonographic results of the breast with progesterone levels in women with fibrocystic mastopathy]. Urbanowicz Z; Buchacz P; Poreba R; Noras K Ginekol Pol; 1996 Aug; 67(8):411-3. PubMed ID: 9139011 [TBL] [Abstract][Full Text] [Related]
43. [Assessment of selected hormonal parameters in patients with mastopathy in postmenopausal period]. Mizia-Stec K; Zych F; Widala E Ginekol Pol; 1998 Feb; 69(2):56-61. PubMed ID: 9591381 [TBL] [Abstract][Full Text] [Related]
44. [Effect of alpha dihydroergocryptine in patients with fibrocystic breast disease]. Castillo E; Garibay M; Mirabent F Ginecol Obstet Mex; 2006 Nov; 74(11):580-4. PubMed ID: 17357577 [TBL] [Abstract][Full Text] [Related]
45. Treatment of fibrocystic disease of the breast with gestrinone, a new trienic synthetic steroid with anti-estrogen, anti-progesterone properties. Coutinho EM; Azadian-Boulanger G Int J Gynaecol Obstet; 1984 Oct; 22(5):363-6. PubMed ID: 6151920 [TBL] [Abstract][Full Text] [Related]
46. [Therapy of mastodynia and simple mastopathy]. Lotze W Zentralbl Gynakol; 1990; 112(18):1151-5. PubMed ID: 2275290 [TBL] [Abstract][Full Text] [Related]
47. Treatment of fibrocystic mastopathy by an antiestrogen, tamoxifen. Shaaban MM; Morad F; Hassan Ael R Int J Gynaecol Obstet; 1980; 18(5):348-50. PubMed ID: 6110580 [TBL] [Abstract][Full Text] [Related]
48. [Treatment of fibrocystic disease of the breast with myrtillus anthocyanins. Our experience]. Leonardi M Minerva Ginecol; 1993 Dec; 45(12):617-21. PubMed ID: 8139788 [TBL] [Abstract][Full Text] [Related]
50. [Effect of chon-ren regulating herbal medicine on hormone level in patients of mammary hyperplasia]. Liu X; Lu D Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Aug; 18(8):475-6. PubMed ID: 11477831 [No Abstract] [Full Text] [Related]
51. Methylxanthine, alcohol-free diet and fibrocystic breast disease: a factorial clinical trial. Parazzini F; La Vecchia C; Riundi R; Pampallona S; Regallo M; Scanni A Surgery; 1986 May; 99(5):576-81. PubMed ID: 3518107 [TBL] [Abstract][Full Text] [Related]
52. Treatment of benign breast disease with vitamin A. Band PR; Deschamps M; Falardeau M; Ladouceur J; Cote J Prev Med; 1984 Sep; 13(5):549-54. PubMed ID: 6527995 [TBL] [Abstract][Full Text] [Related]
53. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy. Vizoso F; Allende MT; Diez MC; Ruibal A Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515 [No Abstract] [Full Text] [Related]
54. Prostate specific antigen and mastopathy. Wiwanitkit V J Endocrinol Invest; 2010 Jun; 33(6):437. PubMed ID: 20631497 [No Abstract] [Full Text] [Related]
57. [Treatment of premenstrual tension syndrome (PMS) with lisuride maleate]. López-Rosales C; Aguilar-Guerrero JA; García-Moreno L Ginecol Obstet Mex; 1996 Dec; 64():556-60. PubMed ID: 9019440 [TBL] [Abstract][Full Text] [Related]
58. Striatal dopamine receptors and adenylyl cyclase activity in a rat model of alcohol addiction: effects of ethanol and lisuride treatment. May T; Wolf U; Wolffgramm J J Pharmacol Exp Ther; 1995 Dec; 275(3):1195-203. PubMed ID: 8531081 [TBL] [Abstract][Full Text] [Related]
59. [Treatment of fibrocystic breast disease with lisuride]. López Rosales C; Romero Espinosa RE; Juárez Vazquez J Ginecol Obstet Mex; 1991 Dec; 59():358-61. PubMed ID: 1819543 [TBL] [Abstract][Full Text] [Related]